UEFA.com works better on other browsers
For the best possible experience, we recommend using Chrome, Firefox or Microsoft Edge.

New WADA prohibited list

The World Anti-Doping Agency has issued a new list of prohibited substances and a new International Standard for Therapeutic Use Exemptions, which came into effect on 1 January 2011.

New WADA prohibited list
New WADA prohibited list ©UEFA.com

List of prohibited substances 2011
The Prohibited List - which can be found in the supporting documentation on the right of the page - is one of the cornerstones of the harmonised fight against doping. It specifies substances and methods prohibited in sport, and its implementation is mandatory for organisations that have adopted the World Anti-Doping Code.
The 2011 list reflects the latest scientific advances and offers a number of changes compared to the 2010 list. The most important changes are:

• New category "S0. Non-approved substances": this section refers to drugs with no current official approval for human therapeutic use (because they are either under development or are discontinued).

• The stimulant methylhexaneamine has been transferred to the list of specified stimulants. As we warned last month, this substance is increasingly being found in nutritional supplements and may be referred to by different names, including "geranium oil" or "geranium root extract". Players are advised to seek advice from their club or national association medical staff before they take any supplement.

• Platelet-derived preparations (e.g. PRP, blood spinning): all routes of administration are now permitted. This means that intramuscular injection is no longer prohibited and so no longer requires a TUE, and that local injection no longer needs to be declared (see below).

Declaration of Use
The requirement to declare the use of certain authorised substances no longer exists. This concerns the inhalation of salbutamol (maximum 1600 micrograms a day) and salmeterol, the local use of glucocorticosteroids, and the local use of platelet-derived preparations.

TUE procedure
One thing that has not changed is that formoterol, terbutaline and other beta-2 agonists (except inhaled salbutamol and salmeterol) are still prohibited and therefore require a TUE before they can be used. The TUE application for these substances must be accompanied by a full medical file as stipulated in the document "Asthma – minimum requirements".

The circular letter which was sent in December to all national associations and to clubs participating in UEFA competitions gives more details on the 2011 Prohibited List. It can also be found in the supporting documentation on the right of the page.

Selected for you